Chicago Partners Investment Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,000
Closed -$5K 822
2017
Q1
$5K Buy
+1,000
New +$5K ﹤0.01% 497